Clinical Trials Directory

Trials / Completed

CompletedNCT04775368

Fibromyalgia Syndrome in France: The Role of Assessment and Management of Sleep Disorders

Syndrome Fibromyalgique en France : Place de l'évaluation et de la Prise en Charge Des Troubles du Sommeil

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
601 (actual)
Sponsor
Centre Hospitalier Emile Roux · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The FIBOBS study is a multi-centered, observational, prospective study carried out within specialized chronic pain structures (CPS) in France. It will estimate the prevalence of sleep disorders, divided into three categories (poor quality of sleep in general, sleep apnea syndrome, restless legs syndrome), using self-questionnaires in patients with Fibromyalgia Syndrome (FMS) consulting within a CPS. The interaction between these sleep disorders and other symptoms of FMS will also be analyzed using self-administered questionnaires. Based on the hypothesis that sleep disorders associated with FMS are only imperfectly assessed and/or treated in CPS, the FIBOBS study will also interview pain physician in order to know both the diagnostic tools used and the recommended management when sleep disorders are suspected in the context of FMS. In addition, this study will provide a better understanding of the symptoms of FMS, their impact and how patients feel.

Conditions

Interventions

TypeNameDescription
OTHERAdministering diagnosis orientation questionnaires for the screening of possible sleep disordersSeveral diagnosis orientation self-questionnaires will be conducted by the patient following his or her inclusion in order to detect, among other things, possible sleep disorders.

Timeline

Start date
2021-04-01
Primary completion
2023-03-07
Completion
2023-03-07
First posted
2021-03-01
Last updated
2023-05-01

Locations

46 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04775368. Inclusion in this directory is not an endorsement.